PNC Financial Services Group’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

PNC Financial Services Group’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-246	Closed	-$5K	–	4922
2022 Q3	$5K	Hold	246	–	–	﹤0.01%	3992
2022 Q2	$2K	Buy	+246	New	+$1.73K	﹤0.01%	4266

PNC Financial Services Group's FMTX Position: Q4 2022 in Review

PNC Financial Services Group sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 246 shares — an estimated $5K sold.

PNC Financial Services Group first reported a position in FMTX in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

PNC Financial Services Group reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
PNC Financial Services Group sold 246 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $5K.
PNC Financial Services Group first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
PNC Financial Services Group's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $5K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on PNC Financial Services Group's 13F filing for Q4 2022, filed 10 Feb 2023.